Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
22
ALOT Quote, Financials, Valuation and Earnings
Last price:
$8.50
Seasonality move
:
1.22%
Day range:
$8.00 - $8.60
52-week range:
$7.53 - $18.25
Dividend yield:
0%
P/E ratio:
16.46x
P/S ratio:
0.41x
P/B ratio:
0.82x
Volume:
61.2K
Avg. volume:
13K
1-year change:
-52.89%
Market cap:
$62.3M
Revenue:
$151.3M
EPS (TTM):
-$1.93
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target UpsideNo price target exists because of limited analyst coverage.
-
Price Target DownsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, AstroNova has 179.87% upside to fair value with a price target of -- per share.
ALOT vs. S&P 500
-
Over the past 5 trading days, AstroNova has overperformed the S&P 500 by 3.55% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
AstroNova does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
AstroNova revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter AstroNova reported revenues of $37.4M.
Earnings Growth
-
AstroNova earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter AstroNova reported earnings per share of -$2.07.
Enterprise value:
103.9M
EV / Invested capital:
--
Price / LTM sales:
0.41x
EV / EBIT:
14.26x
EV / Revenue:
0.69x
PEG ratio (5yr expected):
1.21x
EV / Free cash flow:
28.21x
Price / Operating cash flow:
16.88x
Enterprise value / EBITDA:
8.81x
Gross Profit (TTM):
$52.7M
Return On Assets:
-9.78%
Net Income Margin (TTM):
-9.58%
Return On Equity:
-16.42%
Return On Invested Capital:
-11.69%
Operating Margin:
2.92%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Income Statement | ||||||
| Revenue | $142.5M | $148.1M | $151.3M | $39.6M | $37.4M | |
| Gross Profit | $48.2M | $51.6M | $52.7M | $14.7M | $12.7M | |
| Operating Income | $5.4M | $8.8M | $4.8M | $3.9M | $1.1M | |
| EBITDA | $9M | $13M | -$4.3M | $5.2M | -$11.1M | |
| Diluted EPS | $0.36 | $0.62 | -$1.93 | $0.36 | -$2.07 | |
| Period Ending | 2021-01-31 | 2022-01-31 | 2023-01-31 | 2024-01-31 | 2025-01-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $60.7M | $63.8M | $79.8M | $76.7M | $78M | |
| Total Assets | $115.5M | $115M | $139.2M | $133.3M | $145.6M | |
| Current Liabilities | $21M | $20M | $37.5M | $29.8M | $46.3M | |
| Total Liabilities | $40.8M | $33.9M | $54.8M | $43M | $69.8M | |
| Total Equity | $74.7M | $81M | $84.4M | $90.3M | $75.8M | |
| Total Debt | $16.9M | $9.2M | $30M | $21.8M | $46.7M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-01-31 | 2024-01-31 | 2025-01-31 | 2024-01-31 | 2025-01-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$2.9M | $12.4M | $4.8M | $6.5M | $2.5M | |
| Cash From Investing | -$17.3M | -$875K | -$20.3M | $404K | -$79K | |
| Cash From Financing | $18.8M | -$11M | $15.4M | -$7M | -$2.2M | |
| Free Cash Flow | -$3.2M | $11.5M | $3.7M | $6.9M | $2.4M | |
ALOT
Sector
Market Cap
$62.3M
$78.3M
Price % of 52-Week High
45.04%
57.88%
Dividend Yield
0%
0%
Shareholder Yield
--
0.76%
1-Year Price Total Return
-52.89%
-18.18%
Beta (5-Year)
0.486
0.870
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$8.01
200-day SMA
Sell
Level
$12.77
Bollinger Bands (100)
Sell
Level
9.11 - 13.45
Chaikin Money Flow
Buy
Level
4.7M
20-day SMA
Sell
Level
$8.40
Relative Strength Index (RSI14)
Sell
Level
40.10
ADX Line
Sell
Level
40.61
Williams %R
Neutral
Level
-55.1948
50-day SMA
Sell
Level
$9.68
MACD (12, 26)
Sell
Level
-0.48
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
6.7M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.3207)
Buy
CA Score
(Annual)
Level (0.1058)
Buy
Beneish M-Score
(Annual)
Level (-3.3226)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (0.8123)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (7)
Buy
Fundamental Score
Level (6)
Revenue Forecast
Earnings per Share Forecast
Company Profile
AstroNova Inc designs, develops, manufactures, and distributes a broad range of specialty printers and data acquisition and analysis systems, including both hardware and software, which incorporate technologies to acquire, store, analyze, and present data in multiple formats sold under the QuickLabel, TrojanLabel and GetLabels brand names. Its target markets for hardware and software products include aerospace, apparel, automotive, avionics, chemicals, computer peripherals, communications, distribution, food and beverage, general manufacturing, packaging, and transportation. It has two segments, Product Identification (PI) and Test & Measurement (T&M). It generates the majority of its revenue from the PI segment that includes specialty printing systems and related supplies.
Stock Forecast FAQ
In the current month, ALOT has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The ALOT average analyst price target in the past 3 months is --.
-
Where Will AstroNova Stock Be In 1 Year?
According to analysts, the consensus estimate is that AstroNova share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About AstroNova?
Analysts are divided on their view about AstroNova share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that AstroNova is a Sell and believe this share price will drop from its current level to --.
-
What Is AstroNova's Price Target?
The price target for AstroNova over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is ALOT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for AstroNova is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of ALOT?
You can purchase shares of AstroNova via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase AstroNova shares.
-
What Is The AstroNova Share Price Today?
AstroNova was last trading at $8.50 per share. This represents the most recent stock quote for AstroNova. Yesterday, AstroNova closed at $8.22 per share.
-
How To Buy AstroNova Stock Online?
In order to purchase AstroNova stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
59
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
55
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Buy
85
HIMS alert for Apr 30
Hims & Hers Health [HIMS] is down 7.91% over the past day.
Buy
54
EAT alert for Apr 30
Brinker International [EAT] is down 1.5% over the past day.
Sell
16
NSP alert for Apr 30
Insperity [NSP] is down 4.79% over the past day.
